1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. SEROLOGICAL TESTING MARKET BY TEST TYPE
5.1. Introduction
5.2. Primary Serological Tests
5.2.1. Enzyme Linked Immunosorbent Assay (ELISA)
5.2.2. Immunofluorescent Antibody Technique (IFAT)
5.2.3. Radio Immunoassay (RIA)
5.3. Secondary Serological Tests
5.3.1. Agglutination Tests
5.3.2. Complement Fixation Tests (CFT)
5.3.3. Precipitation Tests
5.4. Serum Neutralization Tests (SNT)
5.4.1. Toxin-antitoxin Tests
5.4.2. Tertiary Binding Tests
6. SEROLOGICAL TESTING MARKET BY APPLICATION
6.1. Introduction
6.2. Rotavirus
6.3. Hepatitis
6.4. HIV
6.5. Endotoxins
6.6. Therapeutic Drug Monitoring
6.7. Other Infectious Diseases
7. SEROLOGICAL TESTING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals and Clinics
7.3. Diagnostic Laboratories
7.4. Blood Banks
7.5. Others
8. SEROLOGICAL TESTING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Serological Research Institute (SERI) (U.K.)
10.2. Chembio Diagnostics, Inc (U.S.)
10.3. Cellex (U.S.)
10.4. Randox Laboratories Ltd (U.K.)
10.5. Abbott (U.S.)
10.6. Bio-Rad Laboratories Inc. (U.S.)
10.7. BD (U.S.)
10.8. Thermo Fisher Scientific Inc. (U.S.)
10.9. Ortho Clinical Diagnostics (U.S.)
10.10. Quest Diagnostics Incorporated (U.S.)
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES